Condition
Locally Advanced Lung Non-Small Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Locally Advanced Lung Non-Small Cell Carcinoma clinical trials that are recruiting, at sites in 3 countries (most in United States (5), Canada (1), Italy (1)). By phase: Phase 1/2 (2), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Locally Advanced Lung Non-Small Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining sotorasib and trastuzumab deruxtecan for advanced KRAS G12C non-small cell lung cancer | Phase 1/2 | Sacramento, California and 8 other locations | Recruiting | Jun 10, 2025 |
| Investigating heart damage from thoracic radiotherapy in lung cancer patients | — | Milan | Recruiting | Apr 12, 2024 |
| Adding high dose targeted radiation to usual treatment for advanced lung cancer | Phase 3 | Birmingham, Alabama and 476 other locations | Recruiting | Nov 22, 2022 |
| Personalized vaccine combined with pembrolizumab for advanced solid tumors | Phase 1/2 | Jacksonville, Florida | Recruiting | Mar 8, 2022 |
| Using papaverine with chemoradiation to treat advanced non-small cell lung cancer | Phase 1 | Duarte, California and 1 other locations | Recruiting | Nov 29, 2021 |
| Assessing heart health in lung cancer patients receiving personalized chemoradiation | — | Houston, Texas | Recruiting | Aug 18, 2021 |
All recruiting trials (6)
-
Combining sotorasib and trastuzumab deruxtecan for advanced KRAS G12C non-small cell lung cancer
This trial tests whether giving sotorasib with trastuzumab deruxtecan is safe and can shrink tumors or slow progression in people with locally advanced or metastatic non-small cell lung cancer that has a KRAS G12C mutation and progressed after prior targeted therapy, immunotherapy, and chemotherapy.
-
Investigating heart damage from thoracic radiotherapy in lung cancer patients
This study is testing how radiation treatment for lung cancer affects heart health in patients to help make treatments safer and more effective.
-
Adding high dose targeted radiation to usual treatment for advanced lung cancer
This study is testing if adding a high dose of targeted radiation to the usual chemotherapy and immunotherapy can help people with advanced lung cancer live longer and feel better.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Using papaverine with chemoradiation to treat advanced non-small cell lung cancer
This study is testing the best dose of papaverine combined with chemotherapy and radiation to see if it helps people with advanced non-small cell lung cancer live longer and control their tumors better.
-
Assessing heart health in lung cancer patients receiving personalized chemoradiation
This study is testing how personalized chemoradiation treatment for lung cancer affects heart health in patients and if adjusting the treatment can help reduce heart disease risk.
Related topics
Quick answers
How many Locally Advanced Lung Non-Small Cell Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (5 trials), Canada (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.